A review of Dengvaxia®: development to deployment
SJ Thomas, IK Yoon - Human vaccines & immunotherapeutics, 2019 - Taylor & Francis
Dengue is the world's most prevalent and important arboviral disease. More than 50% of the
world's population lives at daily risk of infection and it is estimated more than 95 million …
world's population lives at daily risk of infection and it is estimated more than 95 million …
[HTML][HTML] Dengue infection
Dengue is widespread throughout the tropics and local spatial variation in dengue virus
transmission is strongly influenced by rainfall, temperature, urbanization and distribution of …
transmission is strongly influenced by rainfall, temperature, urbanization and distribution of …
[HTML][HTML] Cross-reactive immunity among flaviviruses
APS Rathore, AL St. John - Frontiers in immunology, 2020 - frontiersin.org
Flaviviruses consist of significant human pathogens responsible for hundreds of millions of
infections each year. Their antigenic relationships generate immune responses that are …
infections each year. Their antigenic relationships generate immune responses that are …
Dengue viruses–an overview
A Tuiskunen Bäck, Å Lundkvist - Infection ecology & epidemiology, 2013 - Taylor & Francis
Dengue viruses (DENVs) cause the most common arthropod-borne viral disease in man
with 50–100 million infections per year. Because of the lack of a vaccine and antiviral drugs …
with 50–100 million infections per year. Because of the lack of a vaccine and antiviral drugs …
[HTML][HTML] Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine
In 2019, the United States Food and Drug Administration accorded restricted approval to
Sanofi Pasteur's Dengvaxia, a live attenuated vaccine (LAV) for dengue fever, a mosquito …
Sanofi Pasteur's Dengvaxia, a live attenuated vaccine (LAV) for dengue fever, a mosquito …
[HTML][HTML] Prospects for a dengue virus vaccine
SS Whitehead, JE Blaney, AP Durbin… - Nature Reviews …, 2007 - nature.com
The number of cases of severe dengue disease continues to grow in endemic areas of
southeast Asia, Central and South America, and other subtropical regions. Children bear the …
southeast Asia, Central and South America, and other subtropical regions. Children bear the …
Dengue viral infections
Dengue viral infections are one of the most important mosquito borne diseases in the world.
They may be asymptomatic or may give rise to undifferentiated fever, dengue fever, dengue …
They may be asymptomatic or may give rise to undifferentiated fever, dengue fever, dengue …
Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised …
Background Dengue virus is the most serious mosquito-borne viral threat to public health
and no vaccines or antiviral therapies are approved for dengue fever. The tetravalent …
and no vaccines or antiviral therapies are approved for dengue fever. The tetravalent …
A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available
T Ishikawa, A Yamanaka, E Konishi - Vaccine, 2014 - Elsevier
Genus flavivirus comprises many important human pathogens causing public health
problems worldwide. Some flavivirus infections are characterized by a relatively high …
problems worldwide. Some flavivirus infections are characterized by a relatively high …
Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand
TP Endy, A Nisalak, S Chunsuttitwat… - The Journal of …, 2004 - academic.oup.com
Background. Infection with any 1 of the 4 dengue viruses (DVs) can produce several
illnesses, ranging from a mild febrile illness to classic dengue fever (DF) to dengue …
illnesses, ranging from a mild febrile illness to classic dengue fever (DF) to dengue …